West Lafayette, IN, United States of America

Keith Lorimer

USPTO Granted Patents = 13 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 42(Granted Patents)

Company Filing History:

Helsinn Therapeutics (u.s.), Inc.

patents

2 out of 3

Axcentua Pharmaceuticals Ab

patents

4. 1 out of 52

Bial-portela Ca & S.a.

patents

5. 1 out of 34

Stiefel Laboratories, Inc.

Harbor Therapeutics, Inc.

patents

9. 1 out of 66

Helsinn Healthcare Sa

Takeda Pharmaceutical Company Limited

patents

where one patent can have more than one assignee

Years Active: 2009-2018

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9975921 - Crystal forms of anamorelin (2018-05-22),

2. 9492425 - Crystalline forms of genistein (2016-11-15),

3. 9314471 - Methods of preparing pharmaceutical solid state forms (2016-04-19),

4. 9012495 - Crystalline forms of genistein (2015-04-21),

5. 8975410 - Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol (2015-03-10),

6. 8518922 - Pharmaceutical solid state forms (2013-08-27),

7. 8466173 - Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide (2013-06-18),

8. 8324383 - Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile (2012-12-04),

9. 8258296 - Crystalline antifungal compounds (2012-09-04),

10. 7879867 - Crystalline antifungal compounds (2011-02-01),

11. 7825138 - Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide (2010-11-02),

12. 7652139 - Clopidogrel salt and polymorphic forms thereof (2010-01-26),

13. 7550592 - Hydromorphone polymorphs (2009-06-23),

Title: The Innovative Contributions of Keith Lorimer

Introduction

Keith Lorimer is a notable inventor based in West Lafayette, Indiana, who has made significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Lorimer's work focuses on the development of crystalline forms of various compounds that have therapeutic applications.

Latest Patents

Among his latest patents, Lorimer has developed crystalline forms of anamorelin, which are useful as pharmaceutical agents. These crystalline forms are designed to act directly on the pituitary gland cells to stimulate the release of growth hormone. Additionally, he has disclosed new crystalline forms of genistein, including various salts such as genistein sodium salt dihydrate and genistein potassium salt dihydrate. These genistein forms are associated with therapeutic compositions that can be used in cancer treatment, highlighting their potential in medical applications.

Career Highlights

Throughout his career, Lorimer has worked with several prominent companies in the pharmaceutical industry, including Palau Pharma and Helsinn Therapeutics (U.S.), Inc. His experience in these organizations has allowed him to contribute to the advancement of pharmaceutical innovations.

Collaborations

Lorimer has collaborated with notable individuals in his field, including Seemon H. Pines and Benjamin Joseph Littler. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Keith Lorimer's innovative work in the pharmaceutical sector, particularly in the development of crystalline forms of anamorelin and genistein, showcases his significant contributions to medical science. His patents reflect a commitment to advancing therapeutic options for patients in need.

This text is generated by artificial intelligence and may not be accurate.